FUJIAN WANCHEN BIOTECHNOLOGY GROUP CO., LTD.

All News Fujian Wanchen Biotechnology Group Co., Ltd.

Equities

300972

CNE100004KH1

End-of-day quote Shenzhen S.E. Other stock markets 23:00:00 02/06/2024 BST			5-day change	1st Jan Change
24.4 ^CNY	-3.06%		-6.48%	-35.00%

04-26	Fujian Wanchen Biotechnology Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
04-22	Fujian Wanchen Biotechnology Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

All News

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Fujian Wanchen Biotechnology Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	04-26	CI
Fujian Wanchen Biotechnology Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	04-22	CI
Certain A Shares of Fujian Wanchen Biotechnology Co., Ltd are subject to a Lock-Up Agreement Ending on 19-APR-2024.	04-18	CI
Fujian Wanchen Biotechnology Group Co., Ltd. announced that it has received CNY 200 million in funding	02-27	CI
Fujian Wanchen Biotechnology Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23/10/23	CI
Fujian Wanchen Biotechnology Co., Ltd Announces Management Appointments	25/09/23	CI
Fujian Wanchen Biotechnology Co., Ltd has Changed its Name to Fujian Wanchen Biotechnology Group Co., Ltd	21/09/23	CI
Fujian Wanchen Biotechnology Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2023	18/08/23	CI
Fujian Wanchen Biotechnology Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023	18/04/23	CI
Fujian Wanchen Biotechnology Co., Ltd announced that it expects to receive CNY 200 million in funding	19/02/23	CI
Nanjing Wanpin Commercial Management Co., Ltd. announced that it expects to receive CNY 7 million in funding from Fujian Wanchen Biotechnology Co., Ltd, Huainan Shengyu Enterprise Management Co., Ltd, Huainan Huixiang Enterprise Management Co., Ltd., Xinghua Dewen Management Consulting Co., Ltd., Xinghua Geometry Management Consulting Co., Ltd., and other investors	27/12/22	CI
Fujian Wanchen Biotechnology Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2022	26/10/22	CI
Fujian Wanchen Biotechnology Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2022	28/08/22	CI
Fujian Wanchen Biotechnology Co., Ltd Announces 2021 Final Profit Distribution Plan to Be Implemented (A Shares), Payment Date: 06 June 2022	26/05/22	CI
Fujian Wanchen Biotechnology Co., Ltd Announces Dividend for 2021	17/05/22	CI
Fujian Wanchen Biotechnology Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2022	28/04/22	CI
Fujian Wanchen Biotechnology Co., Ltd Proposes Final Cash Dividend for 2021	26/04/22	CI
Fujian Wanchen Biotechnology Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2021	25/04/22	CI
Fujian Wanchen Biotechnology Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2021	26/10/21	CI
Fujian Wanchen Biotechnology : Edible Fungus Maker Wanchen Biotechnology to List Nearly 1.3% Stake Post IPO Lockup	21/10/21	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News Fujian Wanchen Biotechnology Group Co., Ltd.

Equities

300972

CNE100004KH1

All News

Filters